In an orthotopic model of pancreatic cancer, oncogenic KRASG12D signaling pathways were shown to drive an immunosuppressive environment by GM-CSF-mediated recruitment of suppressive myeloid populations, which could affect the function of effector CD8 T cells (46). This evidence concerns the gene CD8A and familial pancreatic carcinoma.